Kim R. Tsuchimoto

Kim R. Tsuchimoto

DirectoratMonopar Therapeutics· In proxies 2022–2025

Pay in FY2023+22% from the year before · Monopar Therapeutics stock -85.6% the same year

Kim R. Tsuchimoto was paid $848.4K in FY2023 (Dec), up 22%. Monopar Therapeutics stock fell 85.6% that year.

Pay$100 in the stock at the end of FY21 → $11
Pay is from the Summary Compensation Table of each Monopar Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Monopar TherapeuticsPublic company · 4 yr
    • Director2022 – Present · 4 yrStock in role +363%
  2. Thiogenesis Therapeutics Corp.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?